It is noteworthy that in the diagnosis of JMML with special emphasis on the molecular detection, patients often need to carry one of the following mutations: somatic mutations in PTPN11, NRAS, KRAS, and germline mutations in NF1 and CBL [1, 4]. Here, KRAS is linked to juvenile myelomonocytic leukemia.